Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP690785.RAgM7_lrJZGr4RerYoohvv0bktj78ww1nFZouvadgqPnA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP690785.RAgM7_lrJZGr4RerYoohvv0bktj78ww1nFZouvadgqPnA130_assertion type Assertion NP690785.RAgM7_lrJZGr4RerYoohvv0bktj78ww1nFZouvadgqPnA130_head.
- NP690785.RAgM7_lrJZGr4RerYoohvv0bktj78ww1nFZouvadgqPnA130_assertion description "[Particularly, ER?, PR, hMLH1, CDKN2A/P16, SFRP1, SFRP2 and SFRP5 revealed a promoter methylation status in endometrioid carcinoma, whereas SFRP4 showed demethylation in cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP690785.RAgM7_lrJZGr4RerYoohvv0bktj78ww1nFZouvadgqPnA130_provenance.
- NP690785.RAgM7_lrJZGr4RerYoohvv0bktj78ww1nFZouvadgqPnA130_assertion evidence source_evidence_literature NP690785.RAgM7_lrJZGr4RerYoohvv0bktj78ww1nFZouvadgqPnA130_provenance.
- NP690785.RAgM7_lrJZGr4RerYoohvv0bktj78ww1nFZouvadgqPnA130_assertion SIO_000772 21709441 NP690785.RAgM7_lrJZGr4RerYoohvv0bktj78ww1nFZouvadgqPnA130_provenance.
- NP690785.RAgM7_lrJZGr4RerYoohvv0bktj78ww1nFZouvadgqPnA130_assertion wasDerivedFrom befree-20150227 NP690785.RAgM7_lrJZGr4RerYoohvv0bktj78ww1nFZouvadgqPnA130_provenance.
- NP690785.RAgM7_lrJZGr4RerYoohvv0bktj78ww1nFZouvadgqPnA130_assertion wasGeneratedBy ECO_0000203 NP690785.RAgM7_lrJZGr4RerYoohvv0bktj78ww1nFZouvadgqPnA130_provenance.